HPV in the etiology of human cancer

被引:927
作者
Munoz, Nubia
Castellsague, Xavier
de Gonzalez, Amy Berrington
Gissmann, Lutz
机构
[1] ICO, F-69005 Lyon, France
[2] Inst Catala Oncol, IDIBELL, Canc Epidemiol & Registrat Unit, Barcelona, Spain
[3] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[4] German Canc Res Ctr, Res Program Infect & Canc, D-6900 Heidelberg, Germany
关键词
HPV; cancer; epidemiology; etiology;
D O I
10.1016/j.vaccine.2006.05.115
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The causal role of human papillomavirus (HPV) in all cancers of the uterine cervix has been firmly established biologically and epidemiologically. Most cancers of the vagina and anus are likewise caused by HPV, as are a fraction of cancers of the vulva, penis, and oropharynx. HPV-16 and -18 account for about 70% of cancers of the cervix, vagina, and anus and for about 30-40% of cancers of the vulva, penis, and oropharynx. Other cancers causally linked to HPV are non-melanoma skin cancer and cancer of the conjunctiva. Although HPV is a necessary cause of cervical cancer, it is not a sufficient cause. Thus, other cofactors are necessary for progression from cervical HPV infection to cancer. Long-term use of hormonal contraceptives, high parity, tobacco smoking, and co-infection with HIV have been identified as established cofactors; co-infection with Chlamydia trachomatis (CT) and herpes simplex virus type-2 (HSV-2), immunosuppression, and certain dietary deficiencies are other probable cofactors. Genetic and immunological host factors and viral factors other than type, such as variants of type, viral load and viral integration, are likely to be important but have not been clearly identified. (c) 2006 Published by Elsevier Ltd.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 38 条
[31]   Chlamydia trachomatis and invasive cervical cancer:: A pooled analysis of the IARC multicentric case-control study [J].
Smith, JS ;
Bosetti, C ;
Muñoz, N ;
Herrero, R ;
Bosch, FX ;
Eluf-Neto, J ;
Meuer, CJLM ;
van den Brule, AJC ;
Franceschi, S ;
Peeling, RW .
INTERNATIONAL JOURNAL OF CANCER, 2004, 111 (03) :431-439
[32]  
Smith JS, 2002, JNCI-J NATL CANCER I, V94, P1604, DOI 10.1093/jnci/94.21.1604
[33]   The role of the E6-p53 interaction in the molecular pathogenesis of HPV [J].
Thomas, M ;
Pim, D ;
Banks, L .
ONCOGENE, 1999, 18 (53) :7690-7700
[34]  
Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt
[35]  
12::AID-PATH431&gt
[36]  
3.0.CO
[37]  
2-F
[38]   Development and duration of human papillomavirus lesions, after initial infection [J].
Winer, RL ;
Kiviat, NB ;
Hughes, JP ;
Adam, DE ;
Lee, SK ;
Kuypers, JM ;
Koutsky, LA .
JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (05) :731-738